Results 71 to 80 of about 23,616 (164)

Prioritizing efficacy over convenience. [PDF]

Am J Respir Crit Care Med
Siddiqui S, Brooks L, Menzies-Gow A, Akuthota P.   +3 more
europepmc   +1 more source

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients. [PDF]

Circulation
Vega RB, O'Mahony G, Barbour AM, Yu H, Knöchel J, Brengdahl J, Hochdörfer T, Bergenholm L, Töppner Carlsson E, Ahnmark A, Underwood CR, Rudvik A, Carter D, Laru J, Gutgsell A, Twaddle L, Garkaviy P, Bogstedt A, Hurt-Camejo E, Miliotis T, Ryaboshapkina M, Hober A, Hubbard B, Serrano-Wu M, Kaushik V, Geschwindner S, McCarthy MC, Lindén D, Rosenmeier JB.   +28 more
europepmc   +1 more source

Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 VATHOS study. [PDF]

ERJ Open Res
Jackson DJ, Wise RA, Papi A, Lugogo N, Chen R, Chami H, Armengol C, Daoud SZ, Nauclér E, Bowen K, Megally A, Sobande O, Patel M.   +12 more
europepmc   +1 more source

Treatment patterns and disease burden of hypereosinophilic syndrome (HES) in the United States: A real-world observational, retrospective cohort study. [PDF]

World Allergy Organ J
Pongdee T, Dolin P, Ding B, Moore AM, Jain P, Rowell J, Edmonds C, Eudicone JM, Peer T, Chan KA, Chen SY.   +10 more
europepmc   +1 more source

Biopharmaceutics

Journal of Pharmacy and Pharmacology, 2007
openaire   +1 more source

Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics. [PDF]

Pulm Ther
Dareng EO, Tran TN, Urbanski H, Finch R, Emerath U, Kurdyukova Y, Jison ML, Bahadori L, Menzies-Gow A, Wang E, Bel EH, de Llano LP, Emmanuel B, Olinger L.   +13 more
europepmc   +1 more source

Airway inflammation and asthma control in patients using salbutamol or budesonide/formoterol reliever: a randomised, controlled study. [PDF]

ERJ Open Res
Martin MJ, Pavord ID, Chalmers JD, Saralaya D, Roy KG, Patel M, Clarke GW, Belton L, Rutgersson A, Gustafson P, Raja Gopal V, Harrison T.   +11 more
europepmc   +1 more source

272 A novel bispecific macrophage engager antibody (BiME) designed for cancer immunotherapy

Journal for ImmunoTherapy of Cancer, 2021
Rui Gao, Dawei Sun, Hongtao Lu, Xiaofeng Niu, Yanan Geng, Haixia Jiang, Zhihao Wu, Yangsheng Qiu   +7 more
doaj   +1 more source

Benralizumab in bronchiectasis: results from the phase 3 MAHALE study. [PDF]

ERJ Open Res
Chalmers JD, Aliberti S, Burr L, Weinreich UM, Bergna MÁ, Åstrand A, Basavanna P, Fan Y, Gatti M, Ho CN, Ivanov S, McCrae C, Román A, Salemio S, Jison M.   +14 more
europepmc   +1 more source

Correction: Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy. [PDF]

Respir Res
Santus P, Oresta B, Finocchiaro D, De Rosa P, Bell J, Caplen M, Carioto J, Bhatt P, Pyenson B, Papi A.   +9 more
europepmc   +1 more source